Successful prevention of bacterial endophthalmitis in eyes with the boston keratoprosthesis

Cornea

Volumn 28, Issue 8, 2009, Pages 896-901

  Durand, Marlene L ^a   Dohlman, Claes H ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antibiotic prophylaxis; Endophthalmitis; Keratoprosthesis; Vancomycin

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; MOXIFLOXACIN; OFLOXACIN; POLYTRIM; VANCOMYCIN;

ADD ON THERAPY; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BURN; ENDOPHTHALMITIS; FOLLOW UP; GRAFT FAILURE; GRAM POSITIVE COCCI; HUMAN; KERATOPROSTHESIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MUCOUS MEMBRANE PEMPHIGOID; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS; RETROSPECTIVE STUDY; SERRATIA; SERRATIA MARCESCENS; SOFT CONTACT LENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STEVENS JOHNSON SYNDROME; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS BODY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CICATRIX; CORNEA; CORNEAL TRANSPLANTATION; ENDOPHTHALMITIS; EQUIPMENT DESIGN; EYE BURNS; EYE DISEASES; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; INCIDENCE; MYCOBACTERIUM INFECTIONS, ATYPICAL; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STEVENS-JOHNSON SYNDROME; TIME FACTORS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 69749086924     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181983982     Document Type: Article

References (11)

1. Kangas TA, Greenfield DS, Flynn HW, et al. Delayed-onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology. 1997;104:746-752.
2. Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmology. 2001;119:484-489. (Pubitemid 32293568)
3. Dohlman CH, Harissi-Dagher M, Khan BF, et al. Introduction to the use of the Boston Keratoprosthesis. Exp Rev Ophthalmol. 2006;1:41-48.
4. Dohlman CH, Dudenhoefer E, Khan BF, et al. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28:72-74. (Pubitemid 41646458)
5. McLellan C, Ngo V, Pasedis S, et al. Testing the long-term stability of vancomycin ophthalmic solution. Int J Pharm Compounding. 2008;12:456-459.
6. The Endophthalmitis Study Group. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmology. 1996;122:830-846.
7. Debry PW, Perkins TW, Heatley G, et al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120:297-300. (Pubitemid 34250049)
8. Muchley ED, Lehrer RA. Late-onset blebitis and endophthalmitis: incidence and outcomes with mitomycin C. Optom Vis Sci. 2004;81:499-504.
9. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea. 2001;20:19-23.
10. Harissi-Dagher M, Khan BF, Schaumberg DA, et al. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea. 2007;26:564-568. (Pubitemid 47164715)
11. Barnes SD, Dohlman, CH, Durand ML. Fungal colonization and infection in the Boston Keratoprosthesis. Cornea. 2007;26:9-15.